1. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. (May 2016) Authors: Girgis, Ragy R; Van Snellenberg, Jared X; Glass, Andrew; Kegeles, Lawrence S; Thompson, Judy L; Wall, Melanie; Cho, Raymond Y; Carter, Cameron S; Slifstein, Mark; Abi-Dargham, Anissa; Lieberman, Jeffrey A Journal: Journal of psychopharmacology Issue: Volume 30:Number 5(2016:May) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗